Member Info for Elartu

Can it be coincidence that FDBK's two biggest shareholders increase by 3 million each in the last couple of days?

https://www.youtube.com/watch?v=FOQPMjKLQQU

Tom Charlton holdings announcement just in - 86,800,000 now (increase of 3,000,000).

https://www.investegate.co.uk/feedback-plc--fdbk-/rns/holding-s--in-company/201906100928516572B/

"Now will you please stop, or I will prepare a dossier to present to LSE, ADVFN, and the FCA, as your behaviour is not acceptable."

There you go, back into keyboard warrior (bully) mode. You've already reported me to one of these groups. You told me yourself. Quite possibly, you've already reported me to more or perhaps all of them. It appears to be your modus operandi.

I'll make a deal with you. You go away for awhile then I won't have to read your nonsense every day and feel obliged to post a response to it in the interest of balance. If you were a reasonable being we could debate our differences with civility but you don't want that. You just want to shut me up so you can continue to post your never ending, unqualified positivity regarding the board of IQAI.

Of course the CLNs will run their full terms, it benefits the holders to do so. It costs them nothing more to keep them full term but they get more shares for doing so. If they took them early you should be asking yourself why? I can think of only one reason and it isn't good.

Re the loan notes and the future company speculation you persist in. You appear to forget that the money from each loan note issuance appears to last between 2-3 months only. The money is used to pay immediate bills and the staff salaries. That March money has already gone. That's why they raised more in May. And will likely need more by September unless hardware sales really take off in the next 2-3 months.

Might I suggest that I am providing figures and you are providing fluff.

• Until mid 2017 Flying Brands was a shell, with no operations.
So you were happy with the board paying themselves £50,500 for doing nothing with a shell and then more than doubling their pay to £125,000 subsequently.

• Stone Checker Software (SCS) reversed into Flying Brands because FBDU was a shell needing a business, and SCS was a business needing a shell.
The 4 million shares given to TB were valued at £120,000 at the time of the SCS transfer don't muddy that with the fact they are only worth £50,000 now. You have neglected the fact that SCS was also a company with almost no assets and a considerable debt to its name. It certainly didn't need a shell. It was a way of shifting a hugely indebted little company out of private hands and into a Plc so letting all IQAI shareholders take on that debt.

• RNS corrections are commonplace, and in IQAI's case the mistake was benign ... probably caused by a late change in the share price.
Are they commonplace? Why aren't the people issuing the RNS bothered with the details? Is it because they run a company like a private fiefdom because with a board of only 3, a Peterhouse Executive Director on the board, and one board member holding a huge percentage of the shares that they know they can get away with running it like one?

• The overall trend in revenues IS accelerating.
£163k down to £39k is not accelerating. Maybe it will be now they have sold 2 pieces of hardware in the last 6 months but we don't know that for sure yet. The bigger question is how much more do they need to sell to meet the £878,648 yearly administrative expenses?

• There is no conflict of interest.
That's just your opinion. Just as it is not mine.

At a premium? Still trying to push that story out to the masses.

March - £268,500 at 6% loan notes convertible 2024.
Each year the loan notes aren't converted the number of shares redeemed is 6% higher than the previous year.
2019 - 13,425,000 shares at 2p
2020 - 14,230,500
2021 - 15,084,330
2022 - 15,989,389
2023 - 16,948,752
2024 - 17,965,677 shares at 1.39154p.

May £250,000 at 6% loan notes convertible 2025.
Each year the loan notes aren't convertible the number of shares redeemed is 6% higher than the previous year.

2019 - 16,666,666 shares at 1.5p
2020 - 17,666,665
2021 - 18,726,664
2022 - 19,850,263
2023 - 21,041,278
2024 - 22,303,754
2025 - 23,641,979 shares at 1.05744p

I am merely asking a few questions about IQAI that I feel require sensible answers. You consider my questions to be 'irrelevant fluff', I do not. True I did call a poster on here a 'twerp' and you perhaps think that to be libel because you believe that poster to be Trevor Brown using another pseudonym.

So other people may judge, here are the questions I have raised.

Why did the IQAI directors pay go from £50,500 in 2017 to £125,000 in the 2018 accounts? What had they done to earn that pay rise?

Why did Trevor Brown say IQAI was fully funded until June '19 but ended up raising money in March '19?

Why did Trevor Brown say FDA clearance was expected by end December '18 but we are still waiting for it today?

Why when Trevor Brown had already raised money in March '19 did he have to raise again two months later in May '19?

Why was the mistake in 29th May '19 RNS not noticed by either Trevor Brown, the IQAI board, or Peterhouse? Were they all a bit too chummy perhaps?

Why does a Peterhouse Executive Director, Qu Li, sits on the 3 person board at IQAI? Do you not consider that a conflict of interest and the board designed to make Trevor Brown all powerful? Do look into Qu Li's part in the LDV vans fiasco by the way. Fascinating.

Why in June '17 did Trevor Brown sell Stone Checker Software Ltd to IQAI for 4,000,000 IQAI shares at a 3p per share, a £120k valuation? Who benefited from that? Trevor Brown with another 4 million shares or IQAI shareholders who took on a company which had, at last count, assets of £1,628 and debts of £213,518.

Why did IQAI state in their last accounts that revenue was accelerating but had revenue in the 1st half year of £126k and only revenue in the 2nd half year of £39k? How is £39k an acceleration from the previous £126k?

What was each resolution passed at today's AGM was actually about?

Yes Jon Cranston still buying.

Was 30,166,667 (8.08%) now 33,750,000 (9.04%).

https://www.investegate.co.uk/feedback-plc--fdbk-/rns/holding-s--in-company/201906071007585246B/

Maybe they saved you from doing something silly.

Some large afternoon buying.

06-Jun-19 15:27:02 0.889p 500,000
06-Jun-19 16:02:02 0.889p 750,000

Perhaps the move upwards hasn't finished yet.

Price has just been lowered to 0.885p and there are 750k available on line.

Spotmark, forgot to say there are plenty of shares available at 0.889p currently. Your broker is doing a poor job if he can't get any for you.

I see a difference of 201 shares not 1 Spotmark.

Regardless, all 3 trades were buys according to the prevailing prices at the time the trades were recorded.

Lots of buying in the last 2 days indicates a possible leak to me. All this stuff about a Times article about AI in the NHS being the cause of the rise feels wrong to me. Would not be surprised to see some news being released by the company next week.

Agree with you Chaz. Extremely unlikely that the rise was caused by this article.

Or this one.

https://www.expresshealthcare.in/cancer-care/ai-has-great-potential-to-enable-better-cancer-care-dr-balaji-ganeshan/411995/

I see all the resolutions were passed at the AGM today. Does anyone here have a list of those resolutions please?

44% up now Chaz.

Hedgehog has just informed me (over on the other board) that he intends to get me banned from LSE for calling Agnes701 a twerp last week. That seems a bit harsh to me but I guess it is easy to offend some people in such a snowflake society.

Antoine Saillant
Data Scientist at Feedback Medical Ltd

February 2019 – Present 4 months
Cambridge, Royaume-Uni

Responsibilities:
- Assist customers with analysis of image data
- Perform analysis of image data and clinical investigations
- Work with the development team assessing and developing new imaging algorithms
- Work with the marketing team on assessing and developing new products

https://www.linkedin.com/in/antoinesaillant?trk=org-employees_mini-profile_cta

I wonder who he worked for before joining Feedback Medical?

Oh, hang on, I don't need to.

LR2 - 09 Dec 2018 - 17:48:02 - 72 of 198

Hi Hulk, Brown does state the company is fully funded until June '19 in the half-year accounts but the accounts figures in that document suggest otherwise. Let's see if I am closer than Brown before money begins to run out. We will know that come end-February.

(IQAI was not funded to June '19 and more money raised on 11th March '19 - LR 1-0 TB)

Also, according to Brown, FDA clearance is expected by end of this month whereas I have some doubts when the TexRAD software integral to StoneChecker will not even be presented for FDA clearance until next June at the earliest.

(IQAI did not get FDA clearance by end of month and still hasn't - LR 2-0 TB)

LR2 - 08 May 2019 - 12:11:47 - 129 of 198

They are probably already almost back to square one and looking for more funds. If they keep delaying payments they can hold off the next funding day a little but I would be surprised if it is more than a couple of months. They need Imaging Biometrics to make a big sale immediately to keep IQAI going or they will be attempting to pass the hat around again very, very soon.

(Hat passed round 3 weeks later on 29th May - 3-0 to me.)

LR2 - 29 May 2019 - 09:07:39 - 181 of 198

Anyone notice the error in this morning's RNS? I'm surprised Peterhouse didn't spot Trevor Brown's mistake. Expect another RNS later today when Trevor reads this post and checks the RNS. Just not good enough Trevor - must try harder.

(4-0 to me - RNS correction issued at 11:51 on 29th May '19)

That will do for now. For the life of me I have no idea why anybody on this board trusts a single word that comes out of TB's mouth.

Not forgetting the Siemens / TexRAD JV of course.